Feed BHC
BH

Bausch Health BHC · NYSE

$6.47 +0.23% (+$0.02)

Market cap
$2.41B
Enterprise value
$21.4B
P/E
-
Forward P/E
1.4x
PEG
-
P/S
0.2x
P/FCF
1.7x
EV/EBITDA
10.4x
ROIC
19.5%
Bruto marža
71.8%
Neto marža
-10.1%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
9.3x
Beta
0.37
Free float
88.6%

O podjetju

Bausch Health Companies Inc. is a Canadian pharmaceutical company focused on the development and manufacturing of medicines and healthcare products. Originally founded in 1959 as Valeant Pharmaceuticals, the company rebranded as Bausch Health in 2018, shifting its focus to products in ophthalmology, dermatology, dental care, and cardiovascular medicine. Bausch Health specializes in prescription drugs, over-the-counter products, and innovative medical devices, and is known for its strong portfolio in ophthalmology and medical technologies.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Thomas J. Appio

Employees

20,300

Headquarters

Laval

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.